Literature DB >> 6786150

The immune spectrum in patients with pulmonary tuberculosis.

T M Daniel, M J Oxtoby, E Pinto, E Moreno.   

Abstract

The immune response to mycobacterial antigens of 65 patients with pulmonary tuberculosis was studied using delayed skin test reactions and enzyme-linked immunosorbent antibody assays. Evidence for a spectrum of immune response was found. Six of 35 patients studied during the first month of therapy had tuberculin skin test anergy. Anergy was not related to state of nutrition or extent of disease, but it may have been associated with radiographically acute disease. The 6 anergic patients had somewhat higher antibody titers to mycobacterial protein, but not polysaccharide antigens, than did nonanergic patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786150     DOI: 10.1164/arrd.1981.123.5.556

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

1.  Generalized immunological decline during long-term experimental infection with Mycobacterium avium.

Authors:  Brad Gilbertson; Christina Cheers
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis.

Authors:  Walid Ben-Selma; Hedi Harizi; Jalel Boukadida
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

Review 3.  Immunopathogenesis in tuberculosis. Part II: Humoral mechanism of resistance.

Authors:  V Seth; U Singh
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

4.  Range of mycobacterial disease.

Authors:  D S Ridley; M J Ridley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21

5.  Humoral immune response in human tuberculosis: immunoglobulins G, A, and M directed against the purified P32 protein antigen of Mycobacterium bovis bacillus Calmette-Guérin.

Authors:  M Turneer; J P Van Vooren; J De Bruyn; E Serruys; P Dierckx; J C Yernault
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

6.  Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice.

Authors:  L Kremer; J Estaquier; I Wolowczuk; F Biet; J C Ameisen; C Locht
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 7.  Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery.

Authors:  Shajo Kunnath-Velayudhan; Maria Laura Gennaro
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

8.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.

Authors:  F O Sánchez; J I Rodríguez; G Agudelo; L F García
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.

Authors:  M E Kleinhenz; J J Ellner; P J Spagnuolo; T M Daniel
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

10.  Modulation of expression of delayed hypersensitivity by mycobacterial antigen 85 fibronectin-binding proteins.

Authors:  H P Godfrey; Z Feng; S Mandy; K Mandy; K Huygen; J De Bruyn; C Abou-Zeid; H G Wiker; S Nagai; H Tasaka
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.